Kiniksa Pharmaceuticals International, p - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
KNSA Nasdaq 2830 www.kiniksa.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Kiniksa Pharmaceuticals International, p

Kiniksa Pharmaceuticals Provides Corporate Update - Jan 12th, 2026 5:30 am
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Jan 7th, 2026 2:01 pm
US High Growth Tech Stocks to Watch in January 2026 - Jan 7th, 2026 4:38 am
High Growth Tech Stocks In The US Market January 2026 - Jan 5th, 2026 4:38 am
Exploring 3 High Growth Tech Stocks In The US Market - Jan 2nd, 2026 10:38 am
US High Growth Tech Stocks to Watch - Jan 1st, 2026 4:38 am
Exploring High Growth Tech Stocks In The US For December 2025 - Dec 30th, 2025 4:38 am
Exploring High Growth Tech Stocks In The US December 2025 - Dec 26th, 2025 4:38 am
Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) - Dec 22nd, 2025 4:50 am
High Growth Tech Stocks To Watch In The US December 2025 - Dec 18th, 2025 4:38 am
US High Growth Tech Stocks To Watch December 2025 - Dec 17th, 2025 4:38 am
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - Nov 27th, 2025 4:28 pm
US High Growth Tech Stocks to Watch in November 2025 - Nov 27th, 2025 4:38 am
Exploring High Growth Tech Stocks in the US Market - Nov 14th, 2025 4:38 am
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London - Nov 12th, 2025 2:01 pm
High Growth Tech Opportunities in the US Market - Nov 5th, 2025 4:38 am
We Think Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Profit Is Only A Baseline For What They Can Achieve - Nov 5th, 2025 3:52 am
New Strong Sell Stocks for Oct. 30th - Oct 30th, 2025 6:25 am
Kiniksa Pharmaceuticals (KNSA): Assessing Valuation After Strong ARCALYST Growth, Raised Guidance, and FDA Orphan Drug Win - Oct 28th, 2025 11:09 pm
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss Estimates - Oct 28th, 2025 6:40 am